XBiotech (XBIT) Change in Receivables (2020 - 2022)
XBiotech (XBIT) posted quarterly Change in Receivables of -$1.5 million for Q4 2022, down 3377.27% year-over-year from $46685.2 in Q4 2021, and down 200.0% quarter-over-quarter from $1.5 million in Q3 2022.
XBiotech (XBIT) Change in Receivables (2020 - 2022) Analysis & Trends
XBiotech's Change in Receivables history runs 3 years deep, the most recent figure standing at -$1.5 million for Q4 2022.
- In Q4 2022, Change in Receivables fell 3377.27% year-over-year to -$1.5 million; the TTM figure through Mar 2023 stood at -$500000.0 (up 57.91% YoY), while the FY2021 annual figure was -$4.1 million, down 200.0% from the prior year.
- Change in Receivables for Q4 2022 stood at -$1.5 million, down from $1.5 million in the prior quarter.
- The five-year high for Change in Receivables was $11.0 million in Q2 2020, with the low at -$14.6 million in Q3 2020.
- The 3-year median for Change in Receivables is -$272000.0 (2021), against an average of $0.0.
- Peak annual rise in Change in Receivables reached 7952.63% in 2022, while the deepest fall reached 3377.27% in 2022.
- XBiotech's Change in Receivables stood at -$1.9 million in 2020, then surged by 97.74% to -$44000.0 in 2021, then slumped by 3377.27% to -$1.5 million in 2022.
- Business Quant data shows XBIT's Change in Receivables at -$1.5 million in Q4 2022, $1.5 million in Q3 2022, and -$500000.0 in Q2 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.55 Bn | 2.84 Bn | 140.20 Mn |
| 2 | Regeneron Pharmaceuticals | 86.53 Bn | 78.54 Bn | 3.93 Bn | 838.50 Mn |
| 3 | Argenx Se | 65.20 Bn | 60.02 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.40 Bn | 55.26 Bn | 52.00 Mn | -53.00 Mn |
| 5 | BeOne Medicines | 42.17 Bn | 37.07 Bn | 1.53 Bn | 117.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.36 Bn | 28.05 Bn | 992.69 Mn | 31.60 Mn |
| 7 | BioNTech SE | 28.74 Bn | 10.34 Bn | 668.28 Mn | 94.29 Mn |
| 8 | Insmed | 27.45 Bn | 26.29 Bn | 358.27 Mn | 37.16 Mn |
| 9 | Royalty Pharma | 27.17 Bn | 26.33 Bn | - | - |
| 10 | XBiotech | 69.80 Mn | 69.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -1.53 Mn |
| Dec 31, 2022 | -1.53 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Sep 30, 2022 | 1.53 Mn |
| Jun 30, 2022 | -500,000.00 |
| Jun 30, 2022 | -500,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Mar 31, 2022 | 500,000.00 |
| Dec 31, 2021 | -44,000.00 |
| Dec 31, 2021 | -44,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Sep 30, 2021 | 19,000.00 |
| Jun 30, 2021 | -1.66 Mn |
| Jun 30, 2021 | -1.66 Mn |
| Mar 31, 2021 | -2.43 Mn |
| Mar 31, 2021 | -2.43 Mn |
| Dec 31, 2020 | -1.95 Mn |
| Dec 31, 2020 | -1.95 Mn |
| Sep 30, 2020 | -14.62 Mn |
| Sep 30, 2020 | -14.62 Mn |